Skip to Main Content

Paper Details

Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.
Eur J Neurol
3
2023
GCIP, Ganglion, Patients, Retinal ganglion cell, clinically isolated syndrome, demyelinating event, multiple sclerosis, patients, relapsing-remitting multiple sclerosis
Author NameAffiliation
Achim BertheleTUM School of Medicine, Technical University of Munich
Alexander U BrandtExperimental and Clinical Research Center, a cooperation between the Max Delbruck Center for Molecular Medicine and the Helmholtz Association, Charite - University Medicine Berlin
Alexander U BrandtExperimental and Clinical Research Center, Charite - University Medicine Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Alexander U BrandtMax Delbruck Center for Molecular Medicine in the Helmholtz Association
Alexander U BrandtCharite - University Medicine Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Alexander U BrandtUniversity of California irvine
Thomas KornTUM School of Medicine, Technical University of Munich
Thomas KornInstitute for Experimental Neuroimmunology, Technical University of Munich
Thomas Korn
Friedemann PaulExperimental and Clinical Research Center, a cooperation between the Max Delbruck Center for Molecular Medicine and the Helmholtz Association, Charite - University Medicine Berlin
Friedemann PaulExperimental and Clinical Research Center, Charite - University Medicine Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Friedemann PaulMax Delbruck Center for Molecular Medicine in the Helmholtz Association
Friedemann PaulCharite - University Medicine Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Bernhard HemmerTUM School of Medicine, Technical University of Munich
Bernhard Hemmer
Bernhard HemmerTUM School of Medicine, Technical University of Munich
Bernhard Hemmer
Hanna ZimmermannExperimental and Clinical Research Center, a cooperation between the Max Delbruck Center for Molecular Medicine and the Helmholtz Association, Charite - University Medicine Berlin
Hanna ZimmermannExperimental and Clinical Research Center, Charite - University Medicine Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Hanna ZimmermannMax Delbruck Center for Molecular Medicine in the Helmholtz Association
Benjamin KnierTUM School of Medicine, Technical University of Munich
  • 1 - 21

Datasets